Pharmaceutical sales are expected to rise by 4.9 percent in 2022 according to the Economist Intelligence Unit (EIU) with the US continuing to lead the world in pharmaceutical sales numbers. This rise will be driven partly by COVID-19 vaccine sales and the development of other anti-COVID treatments and will also be boosted by the recovery and demands for non-COVID care and elective surgeries that were postponed during the pandemic. Changes in legislation that are expected to come into effect by the end of the year in the EU, for example, could also change the pharmaceutical landscape and boost sales. In China, legislation changes are making it easier to import and register medicines, including innovative drugs.
Made with Visme Infographic Maker
Although even the USA is now undergoing high-profile debates about drug pricing, pharmaceutical prices are expected to accelerate over the next few years, with supply chain issues and energy prices driving up production costs in the short term. Sourcing Active Pharmaceutical Ingredients (APIs) from Asia will continue to be a bottleneck with pharma companies forced to pass these expenses onto their customers.Made with Visme Infographic Maker
Read more about five key trends to watch in global healthcare and life sciences in 2022 here
